This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Congenital Structural Myopathy
Information about Congenital Structural Myopathy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Congenital Structural Myopathy
Most recent studies have shown that Congenital Structural Myopathy shares some biological mechanisms with atrophy, blepharoptosis, central-core-myopathy-(disorder), charcot-marie-tooth-disease, congenital-fiber-type-disproportion, congenital-myopathy-(disorder), dystrophy, muscle-hypotonia, muscle-weakness, muscular-atrophy, muscular-dystrophy, myopathies-nemaline, myopathy, myotonic-dystrophy, neuromuscular-diseases, ophthalmoplegia, weakness.
Among the many pathways, these few ones have gauged particular interests from scientists studying Congenital Structural Myopathy, and have been seen in publications frequently: Autophagy, Cell Adhesion, Cell Growth, Cell Proliferation, Clathrin-mediated Endocytosis, Endocytosis, Exocytosis, Innervation, Lipid Storage, Localization, Muscle Atrophy, Muscle Contraction, Muscle Hypertrophy, Myelination, Nuclear Migration, Pathogenesis, Reflex, Regeneration, Translation, Transport
Quite a number of genes have been found to play important roles in Congenital Structural Myopathy, such as ACTA1, BIN1, DES, DMD, DNM2, DYSF, MTM1, MTMR1, MTMR14, MTMR2, MYH14, RYR1, SBF1, SBF2, SCTR, SNCG, TPM3, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.